Literature DB >> 12842078

Role of bone marrow-derived cells in tumor angiogenesis and treatment.

Rakesh K Jain, Dan G Duda.   

Abstract

The role of bone marrow-derived cells in tumor neovascularization is currently the subject of intense research and debate. Two recent studies offer novel yet somewhat conflicting evidence for the role of these cells in tumor growth and neovascularization. These results have significant implications for tumor biology and treatment. At the same time, they raise many questions, which must be addressed for translating these important findings into new, improved treatment strategies.

Entities:  

Mesh：

Year:  2003        PMID： 12842078     DOI： 10.1016/s1535-6108(03)00138-7

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  19 in total

1.  Myeloid lineage progenitors give rise to vascular endothelium.

Authors:  Alexis S Bailey; Holger Willenbring; Shuguang Jiang; Daniel A Anderson; David A Schroeder; Melissa H Wong; Markus Grompe; William H Fleming
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-18       Impact factor: 11.205

2.  A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature.

Authors:  Hui Jin; Aparna Aiyer; Jingmei Su; Per Borgstrom; Dwayne Stupack; Martin Friedlander; Judy Varner
Journal:  J Clin Invest       Date:  2006-02-23       Impact factor: 14.808

Review 3.  Applying nanomedicine in maladaptive inflammation and angiogenesis.

Authors:  Amr Alaarg; Carlos Pérez-Medina; Josbert M Metselaar; Matthias Nahrendorf; Zahi A Fayad; Gert Storm; Willem J M Mulder
Journal:  Adv Drug Deliv Rev       Date:  2017-05-12       Impact factor: 15.470

Review 4.  Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?

Authors:  Rakesh R Ramjiawan; Arjan W Griffioen; Dan G Duda
Journal:  Angiogenesis       Date:  2017-03-30       Impact factor: 9.596

5.  Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo.

Authors:  Mark Stroh; John P Zimmer; Dan G Duda; Tatyana S Levchenko; Kenneth S Cohen; Edward B Brown; David T Scadden; Vladimir P Torchilin; Moungi G Bawendi; Dai Fukumura; Rakesh K Jain
Journal:  Nat Med       Date:  2005-05-08       Impact factor: 53.440

6.  Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors.

Authors:  Dan G Duda; Kenneth S Cohen; Sergey V Kozin; Jean Y Perentes; Dai Fukumura; David T Scadden; Rakesh K Jain
Journal:  Blood       Date:  2005-12-08       Impact factor: 22.113

7.  Neurotrophins promote revascularization by local recruitment of TrkB+ endothelial cells and systemic mobilization of hematopoietic progenitors.

Authors:  Pouneh Kermani; Dahlia Rafii; David K Jin; Paul Whitlock; Wendy Schaffer; Anne Chiang; Loic Vincent; Matthias Friedrich; Koji Shido; Neil R Hackett; Ronald G Crystal; Shahin Rafii; Barbara L Hempstead
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 8.  Nanotheranostics of circulating tumor cells, infections and other pathological features in vivo.

Authors:  Jin-Woo Kim; Ekaterina I Galanzha; David A Zaharoff; Robert J Griffin; Vladimir P Zharov
Journal:  Mol Pharm       Date:  2013-02-25       Impact factor: 4.939

Review 9.  New molecular targets in angiogenic vessels of glioblastoma tumours.

Authors:  Joshua C Anderson; Braden C McFarland; Candece L Gladson
Journal:  Expert Rev Mol Med       Date:  2008-08-07       Impact factor: 5.600

10.  CD133+ circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients.

Authors:  L Vroling; J S W Lind; R R de Haas; H M W Verheul; V W M van Hinsbergh; H J Broxterman; E F Smit
Journal:  Br J Cancer       Date:  2009-12-15       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.